BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 21663411)

  • 1. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the immunologic microenvironment of astrocytomas.
    Hewedi IH; Radwan NA; Shash LS; Elserry TH
    Cancer Manag Res; 2013; 5():293-9. PubMed ID: 24039448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
    Klein R; Roggendorf W
    Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.
    Prosniak M; Harshyne LA; Andrews DW; Kenyon LC; Bedelbaeva K; Apanasovich TV; Heber-Katz E; Curtis MT; Cotzia P; Hooper DC
    Clin Cancer Res; 2013 Jul; 19(14):3776-86. PubMed ID: 23741072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors.
    Liebrich M; Guo LH; Schluesener HJ; Schwab JM; Dietz K; Will BE; Meyermann R
    Arch Immunol Ther Exp (Warsz); 2007; 55(1):41-7. PubMed ID: 17221335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patients.
    Kemmerer CL; Schittenhelm J; Dubois E; Neumann L; Häsler LM; Lambert M; Renovanz M; Kaeser SA; Tabatabai G; Ziemann U; Naumann U; Kowarik MC
    BMC Cancer; 2021 Oct; 21(1):1108. PubMed ID: 34654395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
    Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
    J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and immunologic changes in patients with malignant brain tumors].
    Khonina NA; Tsentner MI; Leplina OIu; Tikhonova MA; Stupak VV; Nikonov SD; Chërnykh ER; Ostanin AA
    Vopr Onkol; 2002; 48(2):196-201. PubMed ID: 12227068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
    García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
    Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
    Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
    J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
    Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
    Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.